Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.08%
SPX
-0.22%
IXIC
-0.51%
FTSE
-0.20%
N225
-0.22%
AXJO
-0.21%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Join our newsletter to keep up to date with us!
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Bioness Medical Acquires Harmonic Bionics to Enhance Neuro-Rehabilitation with Robotics

publisher logo
Cashu
2 days ago
Cashu TLDR
  • Bioness Medical acquired Harmonic Bionics to enhance neuro-rehabilitation with a new bilateral robotic exoskeleton.
  • The robotic exoskeleton aligns with scapulohumeral rhythm, improving therapy for neurological impairment recovery.
  • This acquisition strengthens Bioness Medical's commitment to innovative solutions in the rehabilitation sector.
hlit Logo
HLIT
Harmonic
0.85%

Bioness Medical Expands Neuro-Rehabilitation Offerings with Acquisition of Harmonic Bionics

Bioness Medical, Inc., a prominent player in neuro-rehabilitation technology, takes a significant step forward in enhancing patient care with its recent acquisition of Harmonic Bionics, Inc., a robotics firm specializing in upper extremity mobility solutions. This strategic acquisition is particularly noteworthy, as it introduces a novel bilateral upper extremity robotic exoskeleton designed to align with a patient’s scapulohumeral rhythm (SHR). Such innovation promises to significantly improve therapy for individuals recovering from neurological impairments, including strokes and traumatic brain injuries, marking a pivotal advancement in rehabilitation practices.

The robotic exoskeleton, once it secures regulatory clearance, will integrate seamlessly into Bioness Medical’s existing product suite, which includes the Vector Gait & Safety System and the Bioness Integrated Therapy System (BITS). These systems have already set a high standard in rehabilitation care, and the addition of the robotic exoskeleton is expected to enhance the therapeutic capabilities offered to healthcare providers. By addressing the specific needs of patients facing musculoskeletal movement challenges, Bioness reaffirms its commitment to delivering cutting-edge solutions that can transform rehabilitation outcomes.

Bioness Medical, with over two decades of experience in the field, prioritizes innovation and excellence in patient care. CEO Todd Cushman emphasizes that this acquisition is not merely a business move but a fulfillment of the company’s promise to enhance clinical technology offerings. The company aims to continue expanding its innovative product portfolio to meet the evolving needs of healthcare providers and patients, thereby paving the way for a brighter future in neuro-rehabilitation. This acquisition also marks a significant milestone for Bioness Medical as it embarks on its journey as an independent entity following its acquisition by Accelmed Partners.

In addition to the development of the robotic exoskeleton, Bioness Medical maintains a strong focus on providing exceptional support to clinicians and patients alike. The integration of advanced robotics into their product line signifies a broader trend in the rehabilitation industry, where technology increasingly plays a crucial role in patient recovery and therapy effectiveness. As Bioness Medical forges ahead, it not only enhances its offerings but also positions itself as a leader in the neuro-rehabilitation sector.

As the healthcare landscape evolves, Bioness Medical’s commitment to innovation and patient-centric solutions stands out. The acquisition of Harmonic Bionics is a testament to the company’s vision for the future of therapy, showcasing the potential of robotics in transforming rehabilitation practices and improving patient outcomes across the board.

The content provided here is for informational purposes only and should not be considered financial or investment advice. Investing in stocks carries risks, including potential loss of principal. Always do your own research and consult with a licensed financial advisor before making any investment decisions. We are not responsible for any losses or damages resulting from your use of this information.

More News

Feature in Progress
This section is under development. Check back soon for updates!